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Authors’ reply
We wholeheartedly agree with 
Karen Ballard and colleagues that self-
reports of vaginal fistula symptoms 
do not have the accuracy of the gold 
standard of pelvic examinations. 
For this reason, we corrected our 
prevalence estimates for the imperfect 
sensitivity and specificity of the 
survey questionnaires. As noted in 
our paper,1 the diﬀ erence between the 
uncorrected and corrected estimates 
suggests that, indeed, an important 
proportion of self-reports could be 
false positives due to confusion with 
incontinence symptoms. Ballard 
and colleagues used information 
about the age and parity of women 
reporting fistula symptoms to 
conclude that there was “an obvious 
error” in our data. It was not possible 
to correct these characteristics for 
misclassification using the Bayesian 
latent class model employed to obtain 
the prevalence estimates. As such, 
it would be misguided to judge the 
validity of our prevalence estimates 
on the basis of these unadjusted data. 
Besides, these characteristics are not 
entirely unexpected since they refer to 
lifetime prevalence and not incidence.
Tunçalp and colleagues2 assessed 
the validity of the Demographic and 
Health Survey ﬁ stula module among 
a subpopulation of Nigerian women 
with perceived ﬁ stula-like symptoms. 
Comparing self-reports to the gold 
standard of medical examinations 
among women reporting symptoms, 
this study estimated the sensitivity 
and speciﬁ city of the module at 92% 
and 83%, respectively. This finding 
should reassure our critics that we are 
in fact not merely estimating “urinary 
incontinence symptoms”, since the 
inclusion of women without perceived 
fistula-like symptoms would have 
considerably improved speciﬁ city.
As for the Ethiopian findings, we 
cannot comment on them based on 
the scarce information provided by 
Ballard and colleagues. We will point 
out, however, that national-level 
estimates of prevalence are expected 
to diverge from regional-level or 
district-level estimates depending on 
levels of within-country heterogeneity 
and the studies’ design. In addition, 
the Ethiopian survey on which our 
inferences are based was conducted 
in 2005. It would have been surprising 
if prevalence had not decreased after 
close to a decade of maternal health 
improvements in sub-Saharan Africa.
The number of studies of vaginal 
ﬁ stula prevalence that used diagnostic 
confirmation in sub-Saharan Africa 
is extremely small, with only two 
published community-based surveys,3 
and this situation is unlikely to 
change in the short term. Self-reports 
of vaginal fistula symptoms from 
nationally representative surveys 
can provide better representation 
and have been conducted in multiple 
countries.4 Adjusting for the imperfect 
sensitivity and specificity, as we 
have done in our analyses, directly 
addressed the concern raised by 
Ballard and colleagues and provided 
similar results to those of a meta-
analysis that only considered studies 
with diagnostic confirmation for 
vaginal ﬁ stula.3
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